CMS Interoperability Standards and Prior Authorization for Drugs Proposed Rule

AMIA submitted comments on CMS’s proposed drug prior authorization rule, supporting FHIR-based interoperability and electronic prior authorization modernization. AMIA urged CMS to reduce administrative burden, improve medication access, strengthen transparency and standards alignment, enhance API performance and patient access, establish safeguards for AI-enabled prior authorization, and advance long-term prior authorization reform.